help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacDonald, B. R.
Right arrow Articles by Roodman, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, B. R.
Right arrow Articles by Roodman, G. D.

Endocrinology, Vol 120, 2326-2333, Copyright © 1987 by Endocrine Society


ARTICLES

Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures

BR MacDonald, N Takahashi, LM McManus, J Holahan, GR Mundy and GD Roodman

Studies of osteoclasts and their precursors in normal and pathological states have been severely hampered by the lack of an in vitro system for forming osteoclasts. We developed a human marrow culture system in which multinucleated cells with several characteristics of osteoclasts form. Multinucleated cells began to form during the first week of culture, with maximum numbers formed after 3 weeks. PTH (25-50 ng/ml) and 1,25-dihydroxyvitamin D3 (10(-10)-10(-8) M) increased formation of these cells, and these effects were inhibited by calcitonin. These multinucleated cells contained nonspecific esterase and tartrate- resistant acid phosphatase, a marker enzyme of osteoclasts, and had several ultrastructural features of osteoclasts. We used this marrow cell culture technique to study a patient with hyperparathyroidism and markedly increased osteoclasts on bone marrow biopsy. The marrow from this patient formed increased numbers of multinucleated cells in vitro. After parathyroidectomy both multinucleated cell formation in vitro and osteoclast numbers on bone biopsy decreased significantly. This long term marrow culture system represents the first demonstration of human osteoclast-like cell formation in vitro. This system should permit studies to evaluate factors controlling formation of cells with certain osteoclast characteristics in vitro and their precursors as well as to evaluate abnormalities in osteoclast formation in patients with metabolic bone disease.


This article has been cited by other articles:


Home page
Stem CellsHome page
L. Duplomb, M. Dagouassat, P. Jourdon, and D. Heymann
Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation
Stem Cells, March 1, 2007; 25(3): 544 - 552.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Feng, G. Anderson, G. Xiao, G. Elliott, L. Leoni, M. Y. Mapara, G. D. Roodman, and S. Lentzsch
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-{kappa}B activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth
Blood, March 1, 2007; 109(5): 2130 - 2138.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Lu, H. Maeda, S. V. Reddy, N. Kurihara, R. Leach, J. L. Anderson, and G. D. Roodman
Cloning and Characterization of the Annexin II Receptor on Human Marrow Stromal Cells
J. Biol. Chem., October 13, 2006; 281(41): 30542 - 30550.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Anderson, M. Gries, N. Kurihara, T. Honjo, J. Anderson, V. Donnenberg, A. Donnenberg, I. Ghobrial, M. Y. Mapara, D. Stirling, et al.
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1
Blood, April 15, 2006; 107(8): 3098 - 3105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J. D. Coffin, and M. M. Hurley
Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone
J. Biol. Chem., May 30, 2003; 278(23): 21258 - 21266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Choi, S. V. Reddy, R. D. Devlin, C. Menaa, H. Chung, B. F. Boyce, and G. D. Roodman
Identification of Human Asparaginyl Endopeptidase (Legumain) as an Inhibitor of Osteoclast Formation and Bone Resorption
J. Biol. Chem., September 24, 1999; 274(39): 27747 - 27753.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. N. Weilbaecher, C. L. Hershey, C. M. Takemoto, M. A. Horstmann, T. J. Hemesath, A. H. Tashjian Jr., and D. E. Fisher
Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3
J. Exp. Med., March 2, 1998; 187(5): 775 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P Boissy, I Machuca, M Pfaff, D Ficheux, and P Jurdic
Aggregation of mononucleated precursors triggers cell surface expression of alphavbeta3 integrin, essential to formation of osteoclast-like multinucleated cells
J. Cell Sci., January 9, 1998; 111(17): 2563 - 2574.
[Abstract] [PDF]


Home page
EndocrinologyHome page
D. M. Biskobing, D. Fan, X. Fan, and J. Rubin
Induction of Carbonic Anhydrase II Expression in Osteoclast Progenitors Requires Physical Contact with Stromal Cells
Endocrinology, November 1, 1997; 138(11): 4852 - 4857.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society